Ligand validation:8CQE

VFO: (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-7-fluoranyl-6-(4-methyl-1,3-thiazol-5-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-oxidanyl-pyrrolidine-2-carboxamide

VFO is a Ligand Of Interest in 8CQE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8CQE_VFO_I_301	51%	63%	0.198	0.953	0.41	0.99	-	2	0	0	100%	1
8CQE_VFO_C_301	44%	58%	0.201	0.929	0.45	1.12	-	5	0	0	100%	1
8CQE_VFO_F_301	43%	60%	0.218	0.943	0.44	1.04	-	4	0	0	100%	1
8CQE_VFO_L_301	43%	61%	0.207	0.93	0.46	0.98	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.